Cochlear rejects ACCC arguments on proposed takeover
Hearing implant manufacturer Cochlear has rejected competition concerns raised by the Australian Competition and Consumer Commission (ACCC) over its proposed acquisition of Oticon Medical. The ACC said in a statement that the proposed takeover of non-surgical bone conductive hearing device manufacturer Oticon raised ‘preliminary competition concerns’ due to there being few global manufacturers of such…
Details